Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins.
AUTOR(ES)
Ho, D D
RESUMO
Serum neutralizing antibodies against the human immunodeficiency virus were frequently detected in infected individuals, and low or absent serum neutralizing titers correlated with poor prognosis. Multiple diverse human immunodeficiency virus isolates were found to exhibit similar susceptibility to neutralization by a panel of human seropositive sera, suggesting that neutralizing antibodies are largely directed against conserved viral domains. Furthermore, utilizing antisera raised against a library of synthetic env peptides, four regions which are important in the neutralization process have been identified within both human immunodeficiency virus envelope glycoproteins (gp41 and gp120). Three of these are in conserved domains and should be considered for inclusion in a candidate vaccine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=254212Documentos Relacionados
- Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins.
- Purified envelope glycoproteins from human immunodeficiency virus type 1 variants induce individual, type-specific neutralizing antibodies.
- Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins.
- Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins.
- Alternate pathways of secretion of simian immunodeficiency virus envelope glycoproteins.
